You are here: Industry Insights > Patent Dispute

News List

Looking at the ADC Territory of Two Industry Pioneers From the DS-8201 Patent Dispute Yefenghong
January 02, 2024
A study by renowned American economist Edwin Mansfield suggests that 60% of new drugs would not be invented without patent protection, highlighting the importance of patent protection in the pharmaceutical industry today.
Alkermes Announces Settlement with Amneal over VIVITROL® Patent Dispute americanpharmaceuticalreview
July 31, 2019
Alkermes has entered into a settlement and license agreement with Amneal Pharmaceuticals to resolve Amneal's inter partes review (IPR) petition challenging U.S. Patent Number 7,919,499 ('499 Patent), an Orange Book-listed patent for ...
Could a patent dispute over Celgene MS hopeful ozanimod tank the BMS deal? fiercepharma
March 15, 2019
As if Bristol-Myers Squibb didn’t have enough to worry about, what with major investors trying to scuttle its $74 billion acquisition of Celgene, now a new concern has emerged—and it involves one of the six drug candidates that BMS executives have cited a
Teva and Neos settle over Cotempla patent dispute pharmaphorum
December 29, 2018
Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over the Israeli firm’s generic version of Neos’ ADHD drug Cotempla XR-ODT (methylphenidate).
Cadila and Supernus settle patent dispute over epilepsy generic pharmafile
March 08, 2017
A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus ...